CP0P

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCP0P
Drug Alias NameCP4PCP0P
ClassificationSmall molecules
Mechanisms of ActionMaltase-glucoamylase inhibitorsAlpha glucosidase inhibitor
TargetsMaltase-glucoamylase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Tokyo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Tokyo
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A